Related Experiment Video
Updated: Jun 1, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Depression among the Moroccan systemic sclerosis
Fahd Wafki1, Bouchra Amine, Yousra Ibn Yacoub
1Department of Rheumatology (Pr N Hajjaj-Hassouni), El Ayachi Hospital, 11000, Sale, Morocco. fahdwafki@yahoo.fr
Insights
Systemic sclerosis (SSc) patients frequently experience depression, with over 77% showing symptoms. Depression correlates with disease severity, pain, and duration, impacting patient well-being.
Area of Science:
- Rheumatology
- Psychiatry
- Epidemiology
Background:
- Systemic sclerosis (SSc) is a chronic autoimmune disease with significant physical and psychological impacts.
- Depression is a common comorbidity in chronic illnesses, yet its prevalence in SSc, particularly in specific populations, requires further investigation.
Purpose of the Study:
- To determine the prevalence and identify predictors of depression among Moroccan patients diagnosed with systemic sclerosis.
- To assess the impact of depression on the functional disability and health status of SSc patients.
Main Methods:
- A cross-sectional study involving 59 Moroccan patients with SSc.
- Assessment using the Patient Health Questionnaire depression scale (PHQ-9), Arabic versions of HAQ and SF-36 for functional disability and health status, clinical histories, and medical examinations.
Main Results:
- A high prevalence of depression was observed, with 77.4% of patients presenting symptoms.
- Major depressive syndrome was diagnosed in 61% and minor depressive syndrome in 16.4% of patients.
- Higher PHQ-9 scores were associated with prolonged disease duration, severe joint pain, greater disease severity, and elevated acute-phase reactants. Depression negatively affected physical and mental health scores.
Conclusions:
- Systemic sclerosis is strongly associated with a high prevalence of depression.
- Routine screening for depression in SSc patients is recommended due to its significant impact on quality of life.
- Identifying depression predictors can aid in targeted interventions for SSc patient care.
Abstract:
To determine the prevalence and predictors factors of depression in Moroccan patients with systemic sclerosis (SSc), we conducted a cross-sectional study of 59 Moroccan patients with systemic sclerosis. Patients were assessed by using the Patient Health Questionnaire depression scale "PHQ-9" and through extensive clinical histories and medical examinations. The Arabic version of HAQ and SF-36 was used to assess functional disability and health status, respectively. Forty-six patients (77.4%) presented symptoms of depression. Thirty six (61%) have a major depressive syndrome and 10 (16.4%) have a minor depressive syndrome. The PHQ-9 score was significantly higher in the patient with prolonged disease duration, severe joint pain, higher disease severity, and important acute-phase reactants. Also, depression had a negative impact on physical and mental scores. Systemic scleroderma is associated with a high prevalence of depression. Screening for depression among patients with SSc is recommended and it should be assessed for routinely.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Depression: Overview
Multiple Sclerosis l: Introduction
